254 related articles for article (PubMed ID: 12824778)
1. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation.
Hazenberg MD; Otto SA; Hamann D; Roos MT; Schuitemaker H; de Boer RJ; Miedema F
AIDS; 2003 Jul; 17(10):1419-24. PubMed ID: 12824778
[TBL] [Abstract][Full Text] [Related]
2. Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.
Zhang Y; de Lara C; Worth A; Hegedus A; Laamanen K; Beverley P; Macallan D
PLoS Pathog; 2013; 9(4):e1003310. PubMed ID: 23637601
[TBL] [Abstract][Full Text] [Related]
3. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.
Nicholson JK; Browning SW; Hengel RL; Lew E; Gallagher LE; Rimland D; McDougal JS
J Acquir Immune Defic Syndr; 2001 Jun; 27(2):105-15. PubMed ID: 11404531
[TBL] [Abstract][Full Text] [Related]
4. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
5. Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.
Ribeiro RM; Hazenberg MD; Perelson AS; Davenport MP
J Virol; 2006 Jan; 80(2):802-9. PubMed ID: 16378982
[TBL] [Abstract][Full Text] [Related]
6. Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution.
van Rij RP; Hazenberg MD; van Benthem BH; Otto SA; Prins M; Miedema F; Schuitemaker H
AIDS Res Hum Retroviruses; 2003 May; 19(5):389-98. PubMed ID: 12803997
[TBL] [Abstract][Full Text] [Related]
7. The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression.
Gijsbers EF; van Sighem A; Harskamp AM; Welkers MR; de Wolf F; Brinkman K; Prins JM; Schuitemaker H; van 't Wout AB; Kootstra NA
PLoS One; 2013; 8(10):e76255. PubMed ID: 24098454
[TBL] [Abstract][Full Text] [Related]
8. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
Gray CM; Schapiro JM; Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
[TBL] [Abstract][Full Text] [Related]
9. The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.
Meijerink H; Indrati AR; van Crevel R; Joosten I; Koenen H; van der Ven AJ
BMC Infect Dis; 2014 Dec; 14():683. PubMed ID: 25495598
[TBL] [Abstract][Full Text] [Related]
10. Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection.
Oswald-Richter K; Grill SM; Leelawong M; Tseng M; Kalams SA; Hulgan T; Haas DW; Unutmaz D
PLoS Pathog; 2007 Apr; 3(4):e58. PubMed ID: 17465678
[TBL] [Abstract][Full Text] [Related]
11. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
Grivel JC; Margolis LB
Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
[TBL] [Abstract][Full Text] [Related]
12. High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.
Fiser AL; Vincent T; Brieu N; Lin YL; Portalès P; Mettling C; Reynes J; Corbeau P
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):529-35. PubMed ID: 20861743
[TBL] [Abstract][Full Text] [Related]
13. Cell turnover and cell tropism in HIV-1 infection.
Davenport MP; Zaunders JJ; Hazenberg MD; Schuitemaker H; van Rij RP
Trends Microbiol; 2002 Jun; 10(6):275-8. PubMed ID: 12088663
[TBL] [Abstract][Full Text] [Related]
14. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
[TBL] [Abstract][Full Text] [Related]
15. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
16. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
17. T-cell dynamics during acute SIV infection.
Mattapallil JJ; Letvin NL; Roederer M
AIDS; 2004 Jan; 18(1):13-23. PubMed ID: 15090825
[TBL] [Abstract][Full Text] [Related]
18. CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4
Roche M; Tumpach C; Symons J; Gartner M; Anderson JL; Khoury G; Cashin K; Cameron PU; Churchill MJ; Deeks SG; Gorry PR; Lewin SR
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852784
[TBL] [Abstract][Full Text] [Related]
19. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
Kolber MA
AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
[TBL] [Abstract][Full Text] [Related]
20. Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission.
Groot F; van Capel TM; Schuitemaker J; Berkhout B; de Jong EC
Retrovirology; 2006 Aug; 3():52. PubMed ID: 16916447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
